Clinical trial

Identification and Analysis of Immunomodulatory Molecules in Patients With…

NCT00223483 · The University of Texas Health Science Center at San Antonio, Other · Completed

Key facts

NCT number NCT00223483
Title Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
Official title Identification and Analysis of Immunomodulatory Molecules From Leukocytes in Patients With Hematologic Disorders and Healthy Volunteers
Lead sponsor The University of Texas Health Science Center at San Antonio, Other
Collaborators US Department of Veterans Affairs U.S. Fed
Status Completed
Study type Observational
Conditions Hematologic Diseases, Healthy Volunteers
Intervention type Genetic
Interventions Isolation of genomic DNA
Enrollment 512
Start date Mar 1, 2005
Primary completion Dec 11, 2020
Completion Jul 14, 2021
First posted Sep 22, 2005
Last update posted Jul 16, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies